As a leader in health and nutrition, something is always happening at Bayer and in the countless communities we serve. Take a look below—and check back often—to explore some of our most exciting stories as they emerge.
Latest News
Bayer’s elinzanetant meets all primary and key secondary endpoints in pivotal OASIS 1 and 2 Phase III studies
AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary endpoint
Bayer Earns Top Score in Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index for Sixth Consecutive Year
Bayer and Broad Institute of MIT and Harvard extend research collaboration to develop new cancer therapies
